A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma

Neuro Oncol. 2024 Jan 5;26(1):5-6. doi: 10.1093/neuonc/noad203.
No abstract available

MeSH terms

  • Adult
  • Brain Neoplasms* / therapy
  • Glioma* / therapy
  • Humans
  • Mutation
  • Protein Subunit Vaccines

Substances

  • Protein Subunit Vaccines